Search

Your search keyword '"Behrens, Frank"' showing total 486 results

Search Constraints

Start Over You searched for: Author "Behrens, Frank" Remove constraint Author: "Behrens, Frank" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
486 results on '"Behrens, Frank"'

Search Results

2. Cost-Effective Platform for the Acquisition of Vital Signs

9. Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial

10. Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units

14. An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study

15. Monitoring and Control of Electrical Machines Using IoT

16. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)

17. Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial

22. IoT- Based Indicator for Industrial Accident Risks

27. The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials

28. Ixekizumab im Vergleich zu Fumarsäureestern und Methotrexat bei der Behandlung der Nagelpsoriasis bei Patienten mit mittelschwerer bis schwerer Psoriasis

29. Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL

32. Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance

33. Charakterisierung von Patienten mit Psoriasisarthritis in der dermatologischen und rheumatologischen Versorgung: Analyse von zwei Registern

40. Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study.

42. Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries

43. Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting

44. Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study

50. Psoriatic Arthritis

Catalog

Books, media, physical & digital resources